Free Trial
OTCMKTS:RCAR

RenovaCare (RCAR) Stock Price, News & Analysis

RenovaCare logo

About RenovaCare Stock (OTCMKTS:RCAR)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
595 shs
Average Volume
3,750 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name RenovaCare, Inc.,to RenovaCare, Inc. in January 2014. RenovaCare, Inc. was incorporated in 1983 and is based in Scottsdale, Arizona.

Receive RCAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RenovaCare and its competitors with MarketBeat's FREE daily newsletter.

RCAR Stock News Headlines

RenovaCare Inc.
RenovaCare, Inc. (RCAR)
New post-election stock warning from Wall Street
If you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first time in history...
Best Midsize Car for 2022
Cheapest Car Insurance New Jersey
See More Headlines

RCAR Stock Analysis - Frequently Asked Questions

Shares of RCAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that RenovaCare investors own include Brainstorm Cell Therapeutics (BCLI), ReNeuron Group (RENE), Coherus BioSciences (CHRS), Fulcrum Therapeutics (FULC), Barrick Gold (GOLD), SCYNEXIS (SCYX) and Teva Pharmaceutical Industries (TEVA).

Company Calendar

Today
11/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:RCAR
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
-99.76
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

This page (OTCMKTS:RCAR) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners